Zacks.com featured expert Kevin Matras highlights: Banner Corp., Repligen Corp., Rentech Nitrogen Partners, L.P. Ryland Group Inc. and Triumph Group, Inc.
CHICAGO, Jan. 10, 2013 /PRNewswire/ -- Stocks in this week's article include: Banner Corp. (NASDAQ: BANR), Repligen Corp. (NASDAQ: RGEN), Rentech Nitrogen Partners, L.P. (NYSE: RNF), Ryland Group Inc. (NYSE: RYL) and Triumph Group, Inc. (NYSE: TGI). Kevin Matras details a good screen to use before and after a company reports this earnings season.
Screen of the Week written by Kevin Matras of Zacks Investment Research:
With earnings having just begun, this is a good screen to use both before and after a company reports.
This screen focuses on more than just earnings surprises, but instead goes over the importance of both earnings surprises and sales surprises, and why as an investor you should care so much about them.
A surprise is more than just a snapshot of an extra few dollars and cents a company made or lost in that one period. Instead, it's a glimpse into what a company's earnings could be, or should be, in the future.
And when these surprises occur, the market tries to quickly re-price that stock to reflect these changes.
While predicting which companies will surprise or not can be difficult, the benefit of an earnings surprise will typically last for one to three months after a surprise is reported.
So you can get in after a company reports a surprise, or you can try and find companies that are more likely to report a surprise, and get in ahead of time.
The screen I'm running today starts off with:
For the rest of this Screen of the Week article please visit Zacks.com at: http://www.zacks.com/commentary/25289/
Sign up now for your free trial today and start picking better stocks immediately. And with the backtesting feature, you can test your ideas to see how you can improve your trading in both up markets and down markets. Don't wait for the market to get better before you decide to do better. Start learning how to be a better trader today: http://at.zacks.com/?id=111
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use. Each week, Zacks Profit from the Pros free email newsletter shares a new screening strategy. Learn more about it here http://at.zacks.com/?id=112
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros http://at.zacks.com/?id=113
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
SOURCE Zacks Investment Research, Inc.
More by this Source
The Zacks Analyst Blog Highlights:Staples, ResMed, Covidien, Stryker and SurModics
Mar 12, 2014, 09:30 ET
Zacks Industry Outlook Highlights: Cigna, Aetna, UnitedHealth Group, Humana and WellPoint
Mar 12, 2014, 09:30 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.